Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients

New Microbiologica

Volumn 21, Issue 3, 1998, Pages 293-308

  Gerna, G ^a   Percivalle, E ^a   Baldanti, F ^a   Sarasini, A ^a   Zavattoni, M ^a   Furione, M ^a   Torsellini, M ^a   Revello, M G ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; FOSCARNET; GANCICLOVIR; MONOCLONAL ANTIBODY; VIRUS ANTIGEN; VIRUS DNA;

AIDS RELATED COMPLEX; ARTICLE; BLOOD; CELL CULTURE; CYTOMEGALIC INCLUSION BODY DISEASE; CYTOMEGALOVIRUS; DRUG EFFECT; FIBROBLAST; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGY; IN SITU HYBRIDIZATION; ISOLATION AND PURIFICATION; LEUKOCYTE; POLYMERASE CHAIN REACTION; VIROLOGY; VIRUS LOAD;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBODIES, MONOCLONAL; ANTIGENS, VIRAL; ANTIVIRAL AGENTS; CELLS, CULTURED; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; FOSCARNET; GANCICLOVIR; HUMANS; IMMUNOCOMPROMISED HOST; IN SITU HYBRIDIZATION; LEUKOCYTES; POLYMERASE CHAIN REACTION; VIRAL LOAD;

EID: 0032114049     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. + T cell homeostasis and function in advanced HIV disease. Science, 277, 112-116.
2. BALDANTI, F., SARASINI, A., SILINI, E., BARBI, M., LAZZARIN A., BIRON, K.K., and GERNA, G. (1995a). Four dually resistant human cytomegalovirus strains from AIDS patients: single mutations in UL97 and UL54 open reading frames are responsible for ganciclovir-and foscarnet-specific resistance, respectively. Scandinavian Journal of Infections Diseases, Suppl. 99, 103-104.
3. BALDANTI, F., SILIM, E., SARASINI, A., TALARICO, C.L., STANAT, S.C., BIRON, K.K., FURIONE, M., BONO, F., PALU, G., and GERNA, G. (1995b). A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate. Journal of Virology, 69, 796-800.
4. BALDANTI, F., UNDERWOOD, M.R., STANAT, S.C., BIRON, K.K., CHOU, S., SARASINI, A., SILINI, E., and GERNA, G. (1996). Single aminoacid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS. Journal of Virology, 70, 1390-1395.
5. BALDANTI, F., ZAVATTONI, M., SARASINI, A., GATTI, M., CHEZZI, L., and GERNA, G. (1997). Comparative quantification of human cytomegalovirus DNA in blood of immunocompromised patients by PCR and Murex Hybrid Capture™ System. Clinical and Diagnostic Virology, 8. 159-165.
6. BIRON, K.K., STANAT, S.C., SORRELL, J.B., FIFE, J.A., KELLER, P.M., LAMBE, C.U., and NELSON, D.J. (1985). Metabolic activation of the nucleoside analog 9- {[2-hydroxy-1-(hydroxymethyl) ethoxy] methyl} guanine in human diploid fibroblasts infected with human cytomegalovirus. Proceedings of the National Academy of Sciences (USA), 82, 2473-2477.
7. BOECKH, M., BOWDEN, R.A., GOODRICH, J.M., PETTINGER, M., and MEYERS, J.D. (1992). Cytomegalovirus antigen detection in peripheral blood leukocytes after allogenic marrow transplantation. Blood, 80, 1358-1364.
8. BOECKH, M., GOOLEY, T.A., MYERSON, D., CUNNINGHAM, T., SCHOCH, G., and BOWDEN, R.A. (1996). Cytomegalovirus pp65-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow trasplantation: a randomized double-blind study. Blood, 88, 4063-4071.
9. BOIVIN, G., GILBERT, C., MORISSETTE, M., HAND-HELD. J., GOYETTE, N., and BERGERON, M.G. (1997). A case of ganciclovir-resistant cytomegalovirus (CMV) retinitis in a patient with AIDS: longitudinal molecular analysis of the CMV viral load and viral mutations in blood compartments. AIDS, 11, 867-873.
10. CHOC, S., ERICE, A., JORDAN, M.C., VERCELLOTTI, G.M., MICHELS, K.R., TALARICO, C.L., STANAT, S.C., and BIRON, K.K. (1995a). Analysis of the UL97 phosphotranferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. Journal of Infectious Diseases, 171, 576-583.
11. CHOU, S., GUENTZEL, S., MICHELS, K.R., MINER, R.C., and DREW, W.L. (1995b). Frequency of UL97 phosphotranferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates. Journal of Infectious Diseases, 172, 239-242.
12. CHOU, S., MAROUSEK, G., GUENTZEL. S., FOLLANSBEE, S.E., POSCHER, M.E., LALKZARI, J.P., MINER, R.C., and DREW, W.L. (1997). Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease. Journal of Infectious Diseases, 176, 786-789.
13. CRUMPACKER, C.S., ed. (1996). Drug resistance in cytomegalovirus: current knowledge and implications for patient management. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 12. (Suppl. 1), S1-S22.
14. GERNA, G., BALDANTI, F., SARASINI, A., FURIONE, M., PERCIVALLE, E., REVELLO, M.G., ZIPETO, D., ZELLA, D., and THE ITALIAN FOSCARNET STUDY GROUP (1994a). Effect of foscarnet treatment on quantitatitation of human cytomegalovirus (HCMV) DNA in blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis. Antimicrobiol Agents and Chemotherapy, 38, 38-44.
15. GERNA, G., BALDANTI, F., ZAVATTONI, M., SARASINL A., PERCIVALLE, E., and REVELLO, M.G. (1992a). Monitoring of ganciclovir sensitivity of multiple human cytomegalovirus strains coinfecting blood of an AIDS patient by an immediate-early antigen plaque assay. Antiviral Research, 19, 333-345.
16. GERNA, G., FURIONE, M., BALDANTI, F., PERCIVALLE, E., COMOLI, P., and LOCATELLI, F. (1995a). Quantitation of human cytomegalovirus DNA in bone marrow transplant recipients. British Journal of Hematology, 91, 674-683.
17. GERNA, G., FURIONE, M., BALDANTI, F., and SARASINI, A. (1994b). Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients. Journal of Clinical Microbiology, 32, 2709-2717.
18. GERNA, G., PAREA, M., PERCIVALLE, E., ZIPETO, D., SILINI, E., BARBARINI, G., and MILANESI, G. (1990a). Human cytomegalovirus viraemia in HIV-1 seropositive patients at various clinical stages of infection. AIDS, 4, 1027-1031.
19. GERNA, G., PERCIVALLE, E., REVELLO, M.G., and MORINI, F. (1993). Correlation of quantitative human cytomegalovirus pp65, p72 and p150-antigenemia, viremia and circulating endothelial giant cells with clinical symptoms and antiviral treatment in immunocompromised patients. Clinical and Diagnostic Virology, 1, 47-59.
20. GERNA, G., REVELLO, M.G., PERCIVALLE, E., and MORINI, F. (1992b). Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. Journal of Clinical Microbiology, 30, 1232-1237.
21. GERNA, G., REVELLO, M.G., PERCIVALLE, E., ZAVATTONI, M., PAREA, M., and BATTAGLIA, M. (1990b). Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins. Journal of Clinical Microbiology, 28, 2681-2688.
22. GERNA, G., SARASINI, A., BALDANTI, F., PERCIVALLE, E., ZELLA, D., REVELLO, M.G., and THE ITALIAN FOSCARNET STUDY GROUP (1997). Quantitative systemic and local evaluation of the antiviral effect of ganciclovir and foscarnet induction treatment on human cytomegalovirus gastrointestinal disease of patients with AIDS. Antiviral Research, 34, 39-50.
23. GERNA, G., SARASINI, A., PERCIVALLE, E, ZAVATTONI, M., BALDANTI, F., and REVELLO, M.G. (1995b). Rapid screening for resistance to ganciclovir and foscarnet of primary isolates of human cytomegalovirus from culturepositive blood samples. Journal of Clinical Microbiology, 33, 738-741.
24. GERNA, G., ZIPETO, D., PAREA, M., REVELLO, M.G., SILINI, E., PERCIVALLE, E, ZAVATTONI, M., GROSSI, P., and MILANESI, G. (1991). Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia and DNAemia. Journal of Infectious Diseases. 164, 488-498.
25. GLEAVES, C.A., SMITH T.F., SHUSTER, E.A., and PEARSON, G.R. (1984). Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low-speed centrifugation and monoclonal antibody to an early antigen. Journal of Clinical Microbiology, 19, 917-919.
26. GONDO, H., MINEMATSU, T., HARADA, M., AKASHI, K., HAYASHI, S., TANIGUCHI, S., YAMASAKI, K., SHIBUYA, T., TAKAMATSU, Y., TESHIMA, T., ETO, T., NAGAFUJI, K., MIZUNO S.-I., HOSODA, K., MORI, R., MINAMISHIMA, Y., and NIHO, Y. (1994). Cytomegalovirus (CMV) antigenaemia for rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation. British Journal of Hematology, 86, 130-137.
27. GOZLAN, J., SALORD, J. M., CHOUAID, C., DUVIVIER, C., PICARD, O., MEYOHAS, M.C., and PETIT, J.C. (1993). Human cytomegalmovirus (HCMV) late-mRNA detection in peripheral blood of AIDS patients: diagnostic value for HCMV diseases compared with those of viral culture and HCMV DNA detection. Journal of Clinical Microbiology, 31, 1943-1945.
28. GREFTE, J.M.M., BLOM, N., VAN DER GIESSEN, M., VAN SON, W., and THE, T.H. (1993). Ultrastructural analysis of circulating cytomegalic cells in patients with active cytomegalovirus infection: evidence for virus production and endothelial origin. Journal of Infectious Diseases, 168, 1110-1118.
29. GREFTE, J.M.M., VAN DER GUN, B.T.F., SCHMOLKE, S., VAN DER GIESSEN, M., VAN SON, W.J., PLACHTER B., JAHN, G., and THE, T.H. (1992). The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomega-lovirus infection. Journal of General Virology, 73, 2923-2932.
30. GROSSI, P., MINOLI, L., DALLA GASPERINA, D., CORONA, A., VIGANÒ, M., and GERNA, G. (1997). II monitoraggio dell'antigenemia pp65 quale strategia di trattamento e di prevenzione della malattia da citomegalovirus umano dopo trapianto di organi toracici. Giornale Italiano di Malattie Infettive, 3, (Suppl. 1), S80-S83.
31. GROSSI, P., MINOLI, L., PERCIVALLE, E., IRISH, W., VIGANÒ, M., and GERNA, G. (1995). Clinical and virological monitoring of human cytomegalovirus infection in 294 heart trasplant recipients. Transplantation, 59, 847-851.
32. LOCATELLI, F., PERCIVALLE, E., COMOLI, P., MACCARIO, R., ZECCA, M., GIORGIANI, G., DI STEFANO, P., and GERNA, G. (1994). Human cytomegalovirus (HCMV) infection in paediatric patients given allogenic bone marrow transplantation: role of early antiviral treatment for HCMV antigenaemia on patients'outcome. British Journal of Hematology, 88, 64-71.
33. LURAIN, N.S., SPAFFORD, L.E., and THOMPSON, K.D. (1994). Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir. Journal of Virology, 68, 4427-4431.
34. LURAIN, N.S., THOMPSON, K.D., HOLMES, E.W., and SULLIVAN READ, G. (1992). Point mutations in the DNA polymerase gene of human cytomegalovirus that result in resistance to antiviral agents. Journal of Virology, 66, 7146-7152.
35. MAZZULLI, T., RUBIN, R.H., FERRARO, M.J., D'AOUILA, R.T., DOVEIKIS, S.A., SMITH, B.R., THE, T.H., and HIRSH, M.S. (1993). Cytomega-lovirus antigenemia: correlation in transplant recipients and in persons with AIDS. Journal of Clinical Microbiology, 31, 2824-2827.
36. MYERS, J.D., FLOURNOY, N., and THOMAS, E.D. (1986). Risk factors for cytomegalovirus infection after human marrow trasplantation. Journal of Infectious Diseases, 153, 478-488.
37. PERCIVALUE, E., RFVELLO, M.G., VAGO L., MORINI, F., and GERNA, G. (1993). Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infection with organ involvement. Journal of Clinical Investigation, 92, 663-670.
38. REVELLO, M.G., BALDANTI, F., FURIONE, M., SARASINI, A., PERCIVALLE, E., ZAVATTONI, M., and GERNA, G. (1995). Polymerase chain reaction for prenatal diagnosis of congenital human cytomegalovirus infection. Journal of Medical Virology, 47, 462-466.
39. REVELLO, M.G., PERCIVALLE, E., DI MATTEO A., MORINI, F., and GERNA, G. (1992). Nuclear expression of the lower matrix protein of human cytomegalovirus in peripheral blood leukocytes of immunocompromised viraemic patients. Journal of General Virology, 73, 437-442.
40. REVELLO, M.G., PHRCIVALLE, E., SARASINI, A., BALDANTI, F., FURIONE, M., and GERNA, G. (1994). Diagnosis of human cytomegalovirus infection of the nervous system by pp65 detection in polymorphonuclear leukocytes of cerebrospinal fluid from AIDS patients. Journal of Infectious Diseases, 170, 1275-1279.
41. REVELLO, M.G., PERCIVALLE, E., ZAVATTONI, M., PAREA, M., GROSSI, P., and GERNA, G. (1989a). Detection of human cytomegalovirus immediate early antigen in leukocytes as a marker of viremia in immunocompromised patients. Journal of Medical Virology, 29, 88-93.
42. REVELLO, M.G., ZAVATTONI, M., PERCIVALLE, E., GROSSI, P., and GERNA, G. (1989b). Correlation between immunofluorescent detection of human cytomegalovirus immediate early antigen in polymorphonuclear leukocytes and viremia. Journal of Infectious Diseases, 160, 159-160.
43. SALTZMAN, R.L., QUIRK, M.R., and JORDAN, M.C. (1992). High levels of circulating cytomegalovirus DNA reflect visceral organ disease in viremic immunosoppressed patients other than marrow recipients. Journal of Clinical Investigation, 90, 1832-1838.
44. SARASINI, A., BALDANTI, F., FURIONE, M., PERCIVALLE, E., BRERRA, R., BARBI, M., and GERNA, G. (1995). Double resistance to ganciclovir and foscarnet of four human cytomegalovirus strains recovered from AIDS patients. Journal of Medical Virology, 47, 237-244.
45. SMITH, I.L., CHERRINGTON, J.M., JILES, R.E., FULLER, M.D., FREEMAN, W.R., and SPECTOR, S.A. (1997). High level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes. Journal of Infectious Diseases, 176, 69-77.
46. SULLIVAN, V., BIRON, K.K., TALARICO, C., STANAT, S.C., DAVIS, M., POZZI, L.M., and COEN, D.M. (1993). A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivatives. Antimicrobial Agents and Chemotherapy, 37, 19-25.
47. SULLIVAN, V., TALARICO, C.L., STANAT, S.C., DAVIS, M., COEN, D.M., and BIRON, K.K., (1992). A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature, 358, 162-164.
48. VAN DEN BERG, A.P., KLOMPMAKER, I.J., HAAGSMA, E.B., SCHOLTEN-SAMPSON, A., BIJLEVELD, C.M.A., SCHIRM, J., VAN DER GIESSEN, M., SLOFF, M.J.H., and THE, T.H. (1991). Antigenemia in the diagnosis and monitoring of active cytomegalovirus infection after liver transplantation. Journal of Infectious Diseases, 164, 265-270.
49. VAN DEN BERG, A.P., VAN DER BIJ, W., VAN SON, W.J., ANEMA, J., VAN DER GIESSEN, M., SCHIRM, J., TEGZESS, A.M., and THE, T.H. (1989). Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation: a report of 130 consecutive patients. Transplantation, 48, 991-995.
50. VAN DER BIJ, W., SCHIRM, J., TORENSMA, R., VAN SON, W.J., TEGZESS, A.M., and THE, T.H. (1988a). Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. Journal of Clinical Microbiology, 26, 2531-2535.
51. VAN DER BIJ, W., TORENSMA, R., VAN SON, W.J., ANEMA, J., SCHIRM, J., TEGZESS, A.M., and THE, T.H. (1988b). Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leukocytes. Journal of Medical Virology, 25, 179-188.
52. WOLF, D.G., and SPECTOR, S.A. (1993). Early diagnosis of human cytomegalovirus diseases in transplant recipients by DNA amplification in plasma. Transplantation, 56, 330-334.